Cell Therapy Committee

 View Only
last person joined: one year ago 

The Cell Therapy Committee monitors the society’s strategic activities in cellular therapy and advises the Board of Directors on strategies to address the current and future hurdles in the cell therapy field. Currently, the committee is charged with address four key hurdles related to opportunities for regulatory consensus and efficiencies, understanding and enhancing product efficacy, solid tumor cell therapy, and host factors.

Marco Ruella, MD
University of Pennsylvania

Shari Pilon-Thomas, PhD
H. Lee Moffitt Cancer Center & Research Institute